Glucidion G 5 (Glucose, Anhydrous, Potassium Chloride, Sodium Chloride)

Glucidion G 5 may be employed in medical practice for several supportive purposes related to fluid and electrolyte management.

• Providing an immediate source of glucose for patients unable to intake carbohydrates orally.
• Replenishing potassium and sodium levels during or after surgical procedures.
• Assisting in the correction of mild electrolyte imbalances in hospitalized patients.
• Supporting hydration and energy needs in patients receiving parenteral nutrition.
• Facilitating the management of hypoglycemia when rapid intravenous glucose is required.

Intravenous administration of Glucidion G 5 can be associated with a range of observed effects, which are generally categorized by frequency and severity.

Common

• Mild nausea or vomiting
• Transient headache
• Local irritation at the infusion site

Serious

• Severe hyperglycemia
• Significant hyperkalemia with cardiac risk
• Fluid overload leading to pulmonary edema

When using Glucidion G 5, healthcare providers should observe several precautionary measures to minimize risks and ensure appropriate patient monitoring.

• Assess baseline blood glucose, potassium, and sodium levels before infusion.
• Adjust infusion rate in patients with renal impairment or heart failure.
• Monitor cardiac rhythm continuously if high potassium concentrations are administered.
• Avoid rapid infusion in patients at risk for fluid overload.
• Use caution in individuals with known hypersensitivity to any component of the solution.
• Re‑evaluate electrolyte status regularly during prolonged therapy.

Glucidion G 5 may interact with other medications or solutions; awareness of these interactions helps prevent adverse outcomes.

Avoid

• Concurrent administration of other potassium‑rich intravenous solutions without adjusting total potassium dose.
• Co‑infusion with high‑glucose formulations that could precipitate severe hyperglycemia.
• Use with medications that prolong the QT interval when significant electrolyte shifts are expected.

Use with caution

• Diuretics that affect potassium balance, requiring close electrolyte monitoring.
• Insulin therapy, as combined effects may alter glucose levels rapidly.
• Calcium channel blockers, especially in the setting of hyperkalemia.